IdentificationGeneric Name(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xyluloseDrugBank Accession NumberDB04240BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose (DB04240)× CloseWeightAverage: 430.4908 Monoisotopic: 430.199153314 Chemical FormulaC24H30O7Synonyms1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1-METHOXY-2-OXY-3,4-DIHYDROXYPENTYL)-8,9-DIHYDROXY-7-(SEC-BUTYL)-ANTHRACENEPharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionNot AvailableAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as anthracenes. These are organic compounds containing a system of three linearly fused benzene rings.KingdomOrganic compoundsSuper ClassBenzenoidsClassAnthracenesSub ClassNot AvailableDirect ParentAnthracenesAlternative ParentsNaphthols and derivatives / Tetralins / Aryl alkyl ketones / 1-hydroxy-4-unsubstituted benzenoids / Monosaccharides / Beta-hydroxy ketones / Acyloins / Vinylogous acids / Alpha-hydroxy ketones / Secondary alcohols / 1,2-diols / Dialkyl ethers / Organic oxides / Hydrocarbon derivatives


 show 4 moreSubstituents1,2-diol / 1-hydroxy-4-unsubstituted benzenoid / 1-naphthol / Acyloin / Alcohol / Alpha-hydroxy ketone / Anthracene / Aromatic homopolycyclic compound / Aryl alkyl ketone / Aryl ketone / Beta-hydroxy ketone / Carbonyl group / Dialkyl ether / Ether / Hydrocarbon derivative / Ketone / Monosaccharide / Organic oxide / Organic oxygen compound / Organooxygen compound / Secondary alcohol / Tetralin / Vinylogous acid


 show 13 moreMolecular FrameworkAromatic homopolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyXGORHSPGULYMCV-HHYQQTLHSA-NInChIInChI=1S/C24H30O7/c1-5-11(2)16-7-6-13-8-14-9-15(24(31-4)23(30)20(27)12(3)25)10-17(26)18(14)22(29)19(13)21(16)28/h6-8,11-12,15,20,24-25,27-29H,5,9-10H2,1-4H3/t11-,12-,15-,20+,24+/m1/s1IUPAC Name(3R)-7-[(2R)-butan-2-yl]-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-8,9-dihydroxy-1,2,3,4-tetrahydroanthracen-1-oneSMILESCC[C@@H](C)C1=C(O)C2=C(O)C3=C(C[C@H](CC3=O)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)C=C2C=C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound5288133PubChem Substance46504902ChemSpider4450362ZINCZINC000012504239PDBe LigandDXAPDB Entries1cp8Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.127 mg/mLALOGPSlogP3.01ALOGPSlogP3.72ChemaxonlogS-3.5ALOGPSpKa (Strongest Acidic)7.9ChemaxonpKa (Strongest Basic)-3.1ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count7ChemaxonHydrogen Donor Count4ChemaxonPolar Surface Area124.29 Å2ChemaxonRotatable Bond Count7ChemaxonRefractivity116.22 m3·mol-1ChemaxonPolarizability46.15 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.8894Blood Brain Barrier-0.7206Caco-2 permeable+0.5201P-glycoprotein substrateSubstrate0.7084P-glycoprotein inhibitor INon-inhibitor0.7175P-glycoprotein inhibitor IIInhibitor0.6555Renal organic cation transporterNon-inhibitor0.9175CYP450 2C9 substrateNon-substrate0.8073CYP450 2D6 substrateNon-substrate0.8346CYP450 3A4 substrateSubstrate0.6193CYP450 1A2 substrateInhibitor0.7572CYP450 2C9 inhibitorNon-inhibitor0.8277CYP450 2D6 inhibitorNon-inhibitor0.7792CYP450 2C19 inhibitorNon-inhibitor0.7548CYP450 3A4 inhibitorNon-inhibitor0.6918CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7438Ames testAMES toxic0.5139CarcinogenicityNon-carcinogens0.8964BiodegradationNot ready biodegradable0.9782Rat acute toxicity2.8088 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.944hERG inhibition (predictor II)Non-inhibitor0.6012  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 